glucose intolerance

pre-diabetic state of hyperglycemia that is associated with insulin resistance and increased risk of cardiovascular pathology. IGT may precede type 2 diabetes mellitus by many years
rdfs:label
"glucose intolerance"@en
skos:altLabel
"Glucose: [intolerance] or [malabsorption]"@en
"Glucose: intolerance"@en
"Glucose: malabsorption"@en
"Malabsorption of glucose"@en
"Malabsorption of glucose (disorder)"@en
schema:description
"pre-diabetic state of hyperglycemia that is associated with insulin resistance and increased risk of cardiovascular pathology. IGT may precede type 2 diabetes mellitus by many years"@en
schema:dateModified "2026-10-15T05:23:08+00:00"^^xsd:dateTime
schema:version 2557182662
wikibase:identifiers 15
wikibase:sitelinks 11
wikibase:statements 28
p:P13204 wd:statement/Q2661464-674BBA35-CEED-452D-80E5-992F854A7FAE
p:P1692 wd:statement/Q2661464-2B09CC73-0DAC-4F93-A236-82F0E8B25A70
p:P1748 wd:statement/Q2661464-58938A11-9D00-4A43-865C-F81B81ED7C8E
p:P1995 wd:statement/Q2661464-DC558D46-C489-47F3-96F1-0627ABF9C948
p:P2176 wd:statement/Q2661464-72A97209-11C1-456D-8F60-417E75649DAE
wd:statement/Q2661464-78F746D3-094E-4BD9-AC58-D33105F55CAA
wd:statement/Q2661464-8CB0D1FD-BE38-4A25-B9C3-8620E16BD36A
wd:statement/Q2661464-BC43AD5C-7151-402C-955E-928136898094
p:P2347 wd:statement/Q2661464-c21cbad8-4542-61a4-31c9-841e61e963a8
p:P279 wd:statement/Q2661464-85FA0CA8-5269-42C6-9214-805CBA009AA8
p:P2888 wd:statement/Q2661464-8D7EC7C2-CC1B-4345-829B-D2EDC7E9C1B5
wd:statement/Q2661464-C853AFCD-D063-4876-A432-A8E2C6375C2E
wd:statement/Q2661464-CEE9704A-50D6-4333-907C-44149E0B8FF4
p:P2892 wd:statement/Q2661464-B3B348EA-0D85-4C5B-817F-7734723B9250
p:P31 wd:statement/Q2661464-59E98FFA-D14D-4656-807B-8689D8798335
p:P3827 wd:statement/Q2661464-AC05172D-5EB0-46E6-9B5D-417B7798F30F
p:P3841 wd:statement/Q2661464-48BDBA09-E7ED-4CBF-8BF7-ABDE565FDD73
p:P4229 wd:statement/Q2661464-C80002E0-596C-471C-BC9E-B78BE2F9122A
wd:statement/Q2661464-CF5C8F04-1076-4234-AAEE-798FCA8B8B29
p:P486 wd:statement/Q2661464-5CB97AF4-8E9E-4037-A468-C55E3C30105B
p:P493 wd:statement/q2661464-05C4E0AE-ECBC-41D9-B989-8C026AFF9FDC
p:P5008 wd:statement/Q2661464-48D7E13F-1DD2-4E81-B2C1-2FE2AEC4BE39
p:P5082 wd:statement/Q2661464-6c814cac-41ac-190a-2823-1bded29b80aa
p:P5270 wd:statement/Q2661464-674BB33D-907E-40A5-9E0F-9C1B7AE427A8
p:P6293 wd:statement/Q2661464-6c7f22c7-4557-01ad-ee0f-3945117584a9
p:P646 wd:statement/Q2661464-3E10555D-6503-4E50-BECC-A3E7487975DA
p:P672 wd:statement/Q2661464-DB413F8B-30D5-4E7B-98C5-19DB2B91CC30
p:P699 wd:statement/Q2661464-7D7C3615-B65D-453C-8FB8-B2D98E5AB475
p:direct-normalized/P2347 <http://www.yso.fi/onto/yso/p25426>
p:direct-normalized/P486 <http://id.nlm.nih.gov/mesh/D018149>
p:direct-normalized/P5270 <http://purl.obolibrary.org/obo/MONDO_0001076>
p:direct-normalized/P6293 <http://www.yso.fi/onto/ysa/Y182137>
p:direct-normalized/P672 <http://id.nlm.nih.gov/mesh/C18.452.394.952.500>
p:direct-normalized/P699 <http://purl.obolibrary.org/obo/DOID_DOID:10603>
wdt:P13204 "u96e973f"
wdt:P1692 "271.3"
wdt:P1748 "C34646"
wdt:P1995 endocrinology
wdt:P2176 dulaglutide
liraglutide
exenatide
albiglutide
wdt:P2347 "25426"
wdt:P279 hyperglycemia
wdt:P2888 <http://identifiers.org/doid/DOID:10603>
<http://purl.obolibrary.org/obo/DOID_10603>
<http://purl.obolibrary.org/obo/HP_0000833>
wdt:P2892 "C0271650"
wdt:P31 type of disease
wdt:P3827 "glucose-tolerance"
wdt:P3841 "HP:0000833"
wdt:P4229 "R73.03"
"R73.09"
wdt:P486 "D018149"
wdt:P493 "790.21"
wdt:P5008 WikiProject Medicine
wdt:P5082 "glukosetoleranse"
wdt:P5270 "MONDO_0001076"
wdt:P6293 "Y182137"
wdt:P646 "/m/0cm834"
wdt:P672 "C18.452.394.952.500"
wdt:P699 "DOID:10603"
Download as:
TurtleJSON-LDRDF/XML
data from SPARQL profile: Wikidata